Serum ferritin is a good indicator for predicting the efficacy of adult HLH induction therapy

Background: Hemophagocytic lymphohistiocytosis (HLH) is a rare clinical syndrome with a high mortality rate. There is no biomarker to predict the early therapeutic response. Objective: Our study explores the significance of serum ferritin in predicting the response of induction therapy. Methods: We...

Descripción completa

Detalles Bibliográficos
Autores principales: Hua, Zhengjie, He, Lingbo, Zhang, Ruoxi, Liu, Menghan, Wang, Zhao, Wang, Yini
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2022
Materias:
Hematology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8820825/
https://www.ncbi.nlm.nih.gov/pubmed/35112955
http://dx.doi.org/10.1080/07853890.2022.2027513

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8820825/
https://www.ncbi.nlm.nih.gov/pubmed/35112955
http://dx.doi.org/10.1080/07853890.2022.2027513

Ejemplares similares